Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

Paloma Shemirani, 23, died at Royal Sussex County Hospital on July 24 2024 after declining treatment for non-Hodgkin lymphoma ...

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

PALOMA Shemirani, who died after refusing treatment for her “treatable” cancer, told a court she was “anti-vax”, an inquest ...

Paloma Shemirani, 23, died after she declined conventional treatment for non-Hodgkin lymphoma - her mother is a well-known ...

Paloma Shemirani, 23, died at Royal Sussex County Hospital on July 24 2024 after refusing treatment for non-Hodgkin lymphoma.

No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...

Understanding the evidence on maternal mortality and its causes is a key to crafting solutions; this brief describes the ...

Air Force Reserve Maj. Gen. John Bartrum has a long history of working in military and public health positions, including the ...